ZA878116B - In vivo cellular tracking - Google Patents

In vivo cellular tracking

Info

Publication number
ZA878116B
ZA878116B ZA878116A ZA878116A ZA878116B ZA 878116 B ZA878116 B ZA 878116B ZA 878116 A ZA878116 A ZA 878116A ZA 878116 A ZA878116 A ZA 878116A ZA 878116 B ZA878116 B ZA 878116B
Authority
ZA
South Africa
Prior art keywords
cells
vivo
lifetimes
sites
cyanine dyes
Prior art date
Application number
ZA878116A
Other languages
English (en)
Inventor
Paul Karl Horan
Karl Horan Paul
Sue Ellen Slezak
Ellen Slezak Sue
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA878116B publication Critical patent/ZA878116B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0097—Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Eye Examination Apparatus (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Treating Waste Gases (AREA)
ZA878116A 1986-10-31 1987-10-29 In vivo cellular tracking ZA878116B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/925,445 US4762701A (en) 1986-10-31 1986-10-31 In vivo cellular tracking

Publications (1)

Publication Number Publication Date
ZA878116B true ZA878116B (en) 1988-08-31

Family

ID=25451745

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA878116A ZA878116B (en) 1986-10-31 1987-10-29 In vivo cellular tracking

Country Status (15)

Country Link
US (1) US4762701A (ja)
EP (1) EP0266195B1 (ja)
JP (1) JP2872243B2 (ja)
KR (1) KR100298682B1 (ja)
AT (1) ATE125710T1 (ja)
AU (1) AU607165B2 (ja)
CA (1) CA1294545C (ja)
DE (1) DE3751434T2 (ja)
DK (1) DK167957B1 (ja)
ES (1) ES2076929T3 (ja)
IE (1) IE70749B1 (ja)
IL (1) IL84294A (ja)
PH (1) PH24539A (ja)
PT (1) PT86030B (ja)
ZA (1) ZA878116B (ja)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989010758A1 (en) * 1988-05-02 1989-11-16 Zynaxis Technologies, Inc. Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
US5135916A (en) * 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
FR2655546B1 (fr) * 1989-12-11 1992-03-13 Assistance Publique Composition pour injection intratumorale, et utilisation pour le marquage prechimiotherapique et preoperatoire, en laserotherapie et en thermotherapie.
DE69227112D1 (de) * 1991-07-16 1998-10-29 Transmed Biotech Inc Verfahren und zusammensetzungen für die gleichzeitige analyse einer vielzahl von analyten
WO1993011120A1 (en) * 1991-11-27 1993-06-10 Zynaxis Technologies, Incorporated Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
US5437274A (en) * 1993-02-25 1995-08-01 Gholam A. Peyman Method of visualizing submicron-size vesicles and particles in blood circulation
AU6365894A (en) * 1993-03-16 1994-10-11 Alliance Pharmaceutical Corporation Fluorocarbon compositions containing a visible or fluorescent label
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US7255851B2 (en) * 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6217847B1 (en) 1994-07-01 2001-04-17 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
DE19500665A1 (de) * 1995-01-12 1996-07-18 Axel Prof Dr Haase Verfahren zur ortsauflösenden Abbildung eines Bereiches eines biologischen Objektes mit Hilfe elektromagnetischer Strahlen unter Applikation von Kontrastmittel
CA2211470A1 (en) * 1995-01-30 1996-08-08 Daiichi Pure Chemicals Co., Ltd. Diagnostic marker
DE19539409C2 (de) * 1995-10-11 1999-02-18 Diagnostikforschung Inst Kontrastmittel für die Nahinfrarot-Diagnostik
US6004536A (en) * 1995-11-14 1999-12-21 Molecular Probes, Inc. Lipophilic cyanine dyes with enchanced aqueous solubilty
US5804389A (en) * 1995-12-29 1998-09-08 Phanos Technologies, Inc. Method for detecting abnormal epithelial cell shedding
DE19603033A1 (de) 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US8349602B1 (en) 1996-04-19 2013-01-08 Xenogen Corporation Biodetectors targeted to specific ligands
US5672333A (en) * 1996-05-13 1997-09-30 Mallinckrodt Medical, Inc. Delta1,6 bicyclo 4,4,0! functional dyes for contrast enhancement in optical imaging
US5723104A (en) * 1996-05-13 1998-03-03 Fung; Ella Y. Monocyclic functional dyes for contrast enhancement in optical imaging
US5989835A (en) * 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US6008010A (en) * 1996-11-01 1999-12-28 University Of Pittsburgh Method and apparatus for holding cells
EP0969878B1 (en) * 1997-02-04 2008-07-02 PHANOS TECHNOLOGIES, Inc. Method for detecting abnormal epithelial cell shedding
US6727071B1 (en) 1997-02-27 2004-04-27 Cellomics, Inc. System for cell-based screening
JP3683591B2 (ja) 1997-02-27 2005-08-17 セロミックス インコーポレイテッド 細胞に基づくスクリーニングシステム
US7117098B1 (en) 1997-02-27 2006-10-03 Cellomics, Inc. Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm
US5976502A (en) * 1997-10-21 1999-11-02 Gholam A. Peyman Method of visualizing particles and blood cells containing a fluorescent lipophilic dye in the retina and choroid of the eye
WO1999025863A1 (en) * 1997-11-14 1999-05-27 Cedars-Sinai Medical Center Transfection and transfer of male germ cells for generation of transgenic species
US6734338B1 (en) 1997-11-14 2004-05-11 Cedars-Sinai Medical Center Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
US7294755B1 (en) 1997-11-14 2007-11-13 Cedars-Sinai Medical Center Genetic modification of male germ cells for generation of transgenic species and genetic therapies
US6986993B1 (en) 1999-08-05 2006-01-17 Cellomics, Inc. System for cell-based screening
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US6351663B1 (en) 1999-09-10 2002-02-26 Akorn, Inc. Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
WO2001042786A2 (en) 1999-12-09 2001-06-14 Cellomics, Inc. System for cell based screening : cell spreading
US20090087450A1 (en) * 2000-01-11 2009-04-02 Greenville Hospital System Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
US6849451B2 (en) 2000-01-11 2005-02-01 Greenville Hospital System Hybrid cells
US20070212338A1 (en) * 2000-01-11 2007-09-13 Greenville Hospital System Hybrid cells
US20030223935A1 (en) * 2001-03-05 2003-12-04 Gray Brian D. Fluorescent membrane intercalating probes and methods for their use
WO2001066153A1 (en) * 2000-03-03 2001-09-13 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
US6689391B2 (en) 2001-03-30 2004-02-10 Council Of Scientific & Industrial Research Natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses
WO2002079391A2 (en) * 2001-04-02 2002-10-10 Cytoprint, Inc. Methods and apparatus for discovering, identifying and comparing biological activity mechanisms
US8521260B2 (en) * 2002-12-02 2013-08-27 Yeda Research And Development Co. Ltd. Characterization of arteriosclerosis by optical imaging
US20060034943A1 (en) * 2003-10-31 2006-02-16 Technology Innovations Llc Process for treating a biological organism
US7776529B2 (en) 2003-12-05 2010-08-17 Life Technologies Corporation Methine-substituted cyanine dye compounds
WO2006031313A2 (en) * 2004-08-05 2006-03-23 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for cell activation
TWI306401B (en) * 2004-08-13 2009-02-21 Nat Health Research Institutes Benzothiazolium compounds
US7598390B2 (en) 2005-05-11 2009-10-06 Life Technologies Corporation Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
AU2005234696B2 (en) 2005-11-18 2012-02-16 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
US11052141B1 (en) 2008-10-02 2021-07-06 Kode Biotech Limited Method of modifying the immune response
US20110229511A1 (en) 2008-10-02 2011-09-22 Stephen Michael Henry Method of modifying the immune response
US10350308B2 (en) * 2010-06-30 2019-07-16 Case Western Reserve University Molecular probes for imaging myelin
EP3893717A4 (en) * 2018-12-12 2022-09-14 Tesseract Health, Inc. BIOMETRIC IDENTIFICATION METHODS
CN111334467A (zh) * 2018-12-18 2020-06-26 北京大学 一种光磁双模态指示细胞，其制备方法，其检测方法及其在体内示踪中的应用
US11737665B2 (en) 2019-06-21 2023-08-29 Tesseract Health, Inc. Multi-modal eye imaging with shared optical path

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3673410A (en) * 1969-06-25 1972-06-27 John H Waite Method of examination of cell samples using a radioactively tagged dye
US4343782A (en) * 1978-04-20 1982-08-10 Shapiro Howard M Cytological assay procedure
US4424201A (en) * 1978-11-28 1984-01-03 Rockefeller University Employment of a mereyanine dye for the detection of malignant leukocytic cells
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
US4401647A (en) * 1980-03-03 1983-08-30 The Regents Of The University Of Ca Radiolabeled neoglycopeptides

Also Published As

Publication number Publication date
US4762701A (en) 1988-08-09
PT86030B (pt) 1990-08-31
EP0266195A1 (en) 1988-05-04
JPS63126833A (ja) 1988-05-30
DK167957B1 (da) 1994-01-10
PT86030A (en) 1987-11-01
AU8040187A (en) 1988-05-05
DK570487D0 (da) 1987-10-30
DE3751434D1 (de) 1995-09-07
DK570487A (da) 1988-05-01
PH24539A (en) 1990-08-03
IL84294A (en) 1992-03-29
ES2076929T3 (es) 1995-11-16
DK167850B1 (da) 1993-12-27
KR880005458A (ko) 1988-06-29
IL84294A0 (en) 1988-03-31
ATE125710T1 (de) 1995-08-15
CA1294545C (en) 1992-01-21
DE3751434T2 (de) 1996-05-15
KR100298682B1 (ko) 2001-11-22
IE872871L (en) 1988-04-30
IE70749B1 (en) 1996-12-30
JP2872243B2 (ja) 1999-03-17
EP0266195B1 (en) 1995-08-02
AU607165B2 (en) 1991-02-28

Similar Documents

Publication Publication Date Title
AU607165B2 (en) In vivo cellular tracking
Lang et al. Creatine kinase, an enzyme of many forms.
Lauf et al. Stimulation of active potassium transport in LK sheep red cells by blood group-L-antiserum
Snyder Influence of temperature and hematocrit on blood viscosity
KR880005457A (ko) 세포 성장률 결정
JPS5767860A (en) Material for multilayer analysis
ATE53127T1 (de) Verfahren zum nachweis von agglutinierten erythrozyten.
EP0218010A3 (en) Ligand detection method and substituted carboxyfluorescein tracers therefor
CA1179259A (en) Assay process with non-boiling denaturation
Bellinger et al. Rapid column-chromatographic measurement of orotic acid
Horn et al. Electron spin resonance studies on properties of ceruloplasmin and transferrin in blood from normal human subjects and cancer patients
Sky-Peck A method for determination of magnesium in serum and urine
Matusik et al. Rapid solubility test for detection of hemoglobin S
UEHARA et al. Elevated polyamine content in erythrocytes of malignant lymphoma patients
Ronald et al. BLOOD PROPERTIES OF AQUATIC VERTEBRATES: I. TOTAL BLOOD VOLUME OF THE ATLANTIC COD, GADUS MORHUA L.
Johnson et al. Optimized spectrophotometric determination of aldehyde dehydrogenase activity in erythrocytes
Husby et al. Oceanographic investigation of the northern Bering Sea and Bering Strait, 8-21 June 1969
Yokoyama et al. Direct immunodiffusion technique for Ig quantitation
Avigad et al. Marking of chloroplast galactolipids with tritium
Berlin Blood Volume: Methods and Results
SU625689A1 (ru) Способ получени пробы крови дл определени объема крови,циркулирующей по сосудам органа
Ye et al. Rapid detection of adenovirus and rotavirus in stools from infants with diarrhea by polyacrylamide gel electrophoresis.
Naumann Urobilinogen in cerebrospinal fluid
JPS56132563A (en) Reagent for testing biological material and use thereof
Strauss et al. BLOOD VOLUME DETERMINATION IN MAN: ADVANTAGES OF THE RADIOACTIVE IODINATED HUMAN SERUM ALBUMIN METHOD